Efficacy of initial triple combination therapy with metformin, dapagliflozin and saxagliptin in drug-naive patients with type 2 diabetes: a randomised controlled trial

被引：0
|
作者：
Kim, N. [1 ]
Kim, J. [2 ]
Moon, J. [3 ]
Lee, Y. -H. [4 ]
Kim, T. [5 ]
Cho, H. [6 ]
Kwak, S. [7 ]
Lim, S. [8 ]
Kim, D. [9 ]
Moon, M. [10 ]
Kim, S. [11 ]
机构：
[1] Korea Univ, Internal Med, Coll Med, Seoul, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Seoul, South Korea
[3] Yeungnam Univ, Coll Med, Daegu, South Korea
[4] Yonsei Univ, Coll Med, Seoul, South Korea
[5] Seoul Med Ctr, Seoul, South Korea
[6] Keimyung Univ, Sch Med, Deagu, South Korea
[7] Seoul Natl Univ Hosp, Seoul, South Korea
[8] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea
[9] Konkuk Univ, Coll Med, Seoul, South Korea
[10] Seoul Natl Univ, Bundang Hosp, Seoul, South Korea
[11] Korea Univ, Coll Med, Seoul, South Korea
来源：
DIABETOLOGIA | 2023年 / 66卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
285
引用
收藏
页码：S151 / S151
页数：1
相关论文
共 50 条
  • [31] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes
    Pfuetzner, A.
    Gurieva, I
    Antsiferov, M.
    Allen, E.
    Ravichandran, S.
    Chen, R.
    [J]. SWISS MEDICAL WEEKLY, 2009, 139 (33-34) : 168S - 169S
  • [32] The Efficacy of Teneligliptin with Metformin in Drug-Naive Type 2 Subjects
    Chudasama, Dipak B.
    Saboo, Banshi D.
    Panchal, Dharmendra
    Patel, Feny
    Saiyed, Mahira
    Hasnani, Dhruvi
    Chavda, Vipul
    Chandarana, Hardik
    Goklani, Rutul
    [J]. DIABETES, 2018, 67
  • [33] Saxagliptin improves glycaemic control either as add-on therapy to metformin or as initial combination therapy with metformin in patients with type 2 diabetes
    Gurieva, I.
    Pfuetzner, A.
    Antsiferov, M.
    Allen, E.
    Ravichandran, S.
    Chen, R.
    [J]. EUROPEAN HEART JOURNAL, 2009, 30 : 226 - 227
  • [34] The Efficacy and Safety of Saxagliptin When Added to Metformin Therapy in Patients With Inadequately Controlled Type 2 Diabetes With Metformin Alone
    DeFronzo, Ralph A.
    Hissa, Miguel N.
    Garber, Alan J.
    Gross, Jorge Luiz
    Duan, Raina Yuyan
    Ravichandran, Shoba
    Chen, Roland S.
    [J]. DIABETES CARE, 2009, 32 (09) : 1649 - 1655
  • [35] Dapagliflozin plus saxagliptin plus metformin triple therapy vs sitagliptin add-on to metformin dual therapy in subgroups of patients with uncontrolled type 2 diabetes
    Del Prato, S.
    Handelsman, Y.
    Mathieu, C.
    Johnsson, E.
    Kurlyandskaya, R.
    Iqbal, N.
    Garcia-Sanchez, R.
    Rosenstock, J.
    [J]. DIABETOLOGIA, 2017, 60 : S20 - S21
  • [36] Efficacy and safety of sitagliptin and the fixed-dose combination of sitagliptin and metformin versus pioglitazone in drug-naive patients with type 2 diabetes
    Perez-Monteverde, A.
    Seck, T.
    Xu, L.
    Liu, G.
    Lee, M. A.
    Sisk, C. McCrary
    Williams-Herman, D. E.
    Kaufman, K. D.
    Goldstein, B. J.
    [J]. DIABETOLOGIA, 2010, 53
  • [37] A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy
    White, Judith L.
    Buchanan, Patricia
    Li, Jia
    Frederich, Robert
    [J]. BMC ENDOCRINE DISORDERS, 2014, 14
  • [38] A randomized controlled trial of the efficacy and safety of twice-daily saxagliptin plus metformin combination therapy in patients with type 2 diabetes and inadequate glycemic control on metformin monotherapy
    Judith L White
    Patricia Buchanan
    Jia Li
    Robert Frederich
    [J]. BMC Endocrine Disorders, 14
  • [39] Long-term 4-year safety of saxagliptin in drug-naive and metformin-treated patients with Type 2 diabetes
    Rosenstock, J.
    Gross, J. L.
    Aguilar-Salinas, C.
    Hissa, M.
    Berglind, N.
    Ravichandran, S.
    Fleming, D.
    [J]. DIABETIC MEDICINE, 2013, 30 (12) : 1472 - 1476
  • [40] Dual Add-on Therapy in Type 2 Diabetes Poorly Controlled With Metformin Monotherapy: A Randomized Double-Blind Trial of Saxagliptin Plus Dapagliflozin Addition Versus Single Addition of Saxagliptin or Dapagliflozin to Metformin
    Rosenstock, Julio
    Hansen, Lars
    Zee, Pamela
    Li, Yan
    Cook, William
    Hirshberg, Boaz
    Iqbal, Nayyar
    [J]. DIABETES CARE, 2015, 38 (03) : 376 - 383
12345